Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia

JOURNAL ARTICLE published 1 May 2018 in JAMA Oncology

Authors: Jorge J. Castillo | Joshua N. Gustine | Steven P. Treon

Status Change to Open Access After Publication

JOURNAL ARTICLE published 1 April 2020 in JAMA Oncology

American College of Surgeons Efforts in Support of Value-Based Metrics—Reply

JOURNAL ARTICLE published 1 February 2021 in JAMA Oncology

Authors: Jill R. Dietz | Peter Pronovost

Aspirin Use and the Risk of Cancer—In Reply

JOURNAL ARTICLE published 1 June 2019 in JAMA Oncology

Authors: Tracey G. Simon | Mollie E. Barnard | Andrew T. Chan

Disseminated Cutaneous Lesions in a Patient With a Medical History of Myelodysplastic Syndrome

JOURNAL ARTICLE published 1 September 2018 in JAMA Oncology

Authors: Seongseok Yun | Lubomir Sokol | Ling Zhang

High-risk Medulloblastoma—Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity

JOURNAL ARTICLE published 1 September 2021 in JAMA Oncology

Authors: Allison M. Martin | Sadhana Jackson

On Diction

JOURNAL ARTICLE published 1 October 2021 in JAMA Oncology

Authors: Brian R. Smith

Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer—In Reply

JOURNAL ARTICLE published 1 July 2019 in JAMA Oncology

Authors: Steven D. Criss | Meghan J. Mooradian | Chung Yin Kong

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?

JOURNAL ARTICLE published 1 March 2018 in JAMA Oncology

Authors: Kadri Altundag

Reporting the Analytical Method Is Essential to Assessing Studies in Which Biomarkers Are a Major Study Objective

JOURNAL ARTICLE published 1 September 2021 in JAMA Oncology

Authors: Huub H. van Rossum | Lennart J. van Winden | Annemieke C. Heijboer

A Lived Experience of Breast Cancer as a Scholar of Intersectionality

JOURNAL ARTICLE published 1 October 2022 in JAMA Oncology

Authors: Kristi Tredway

Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials—Reply

JOURNAL ARTICLE published 1 October 2022 in JAMA Oncology

Authors: Bishal Gyawali | Elizabeth Eisenhauer | Michael Brundage

Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer

JOURNAL ARTICLE published 1 October 2022 in JAMA Oncology

Authors: Michael C. Topf | F. Christopher Holsinger | Mihir Patel

Balancing Benefit, Risk, and Time to New Cancer Therapies

JOURNAL ARTICLE published 1 January 2016 in JAMA Oncology

Authors: Howard (Jack) West

Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting

JOURNAL ARTICLE published 1 December 2015 in JAMA Oncology

Authors: Joseph Alvarnas | Guy R. Majkowski | Alexandra M. Levine

Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection

JOURNAL ARTICLE published 1 September 2015 in JAMA Oncology

Authors: Annie Guérin | Medha Sasane | Christopher Hunt Keir | Genevieve Gauthier | Alexander R. Macalalad | Eric Q. Wu | Anthony P. Conley

Affiliation Added

JOURNAL ARTICLE published 1 April 2019 in JAMA Oncology

Missing Conflict of Interest Disclosure

JOURNAL ARTICLE published 1 October 2018 in JAMA Oncology

Incorrect Trial Database Number

JOURNAL ARTICLE published 1 November 2017 in JAMA Oncology

Error in the Figure

JOURNAL ARTICLE published 1 December 2019 in JAMA Oncology